- Gemmell CG, Peterson PK, Schmeling D, et al. Potentiation of opsonization and phagocytosis of
Streptococcus pyogenes following growth in the presence of clindamycin. J Clin Invest 1981; 67:
1249–1256. - Stevens DL, Ma Y, Salmi DB, et al. Impact of antibiotics on expression of virulence-associated
exotoxin genes in methicillin-sensitive and methicillin-resistant Staphylococcus aureus. J Infect Dis
2007; 195(2):202–211. - Kaul R, McGeer A, Norrby-Teglund A, et al. Intravenous immunoglobulin therapy for streptococcal
toxic shock syndrome—a comparative observational study. Canadian Streptococcal Study Group.
Clin Infect Dis 1999; 28:800–807. - Darenberg J, Ihendyane N, Sjolin J, et al. Intravenous immunoglobulin G therapy in streptococcal
toxic shock syndrome: a European randomized, double blind, placebo controlled trial. Clin Infect
Dis 2003; 37:333–340. - Norrby-Telgund A, Basma H, Anderson J, et al. Varying titres of neutralizing antibodies to
streptococcal superantigens in different preparations of normal polyspecific immunoglobulin G
(IVIG): implications for therapeutic efficacy. Clin Infect Dis 1998; 26:631–638. - Harrison OB, Robertson BD, Faust SN, et al. Analysis of pathogen host cell interactions in purpura
fulminans: expression of capsule, type IV pilli, and Por A by Neisseria meningitidis in vivo. Infect
Immun 2002; 70:193–201. - Carpenter CT, Kaiser AB. Purpura fulminans in pneumococcal sepsis: case report and review. Scand
J Infect Dis 1997; 29(5):479–483. - Fourrier F, Lestavel P, Chopin C, et al. Meningococcemia and purpura fulminans in adults: acute
deficiencies of proteins C and S and early treatment with antithrombin III concentrates. Intensive
Care Med 1990; 16(2):121–124. - Kravitz GR, Dries DJ, Peterson ML, et al. Purpura fulminans due to Staphylococcus aureus. Clin
Infect Dis 2005; 40:941–947. - Fridkin SK, Hageman JC, Morrison M, et al. Methicillin resistant Staphylococcus aureus disease in
three communities. N Engl J Med 2005; 352:1436–1444. - Johnson LB, Saravolatz LD. Community-acquired MRSA: current epidemiology and management
issues. Infect Med 2005; 22:16–20. - Abrahamian FM, Talan DA. Management of skin and soft tissue infection in the emergency
department. Infect Dis Clin North Am 2008; 89–116. - Moran GJ, Krishnadasan A, Gorwitz RJ, et al. Methicillin-resistant S. aureus infections among
patients in the emergency department. N Engl J Med 2006;355(7):666–674. - King MD, Humphrey BJ, Wang YF, et al. Emergence of community-acquired methicillin-resistant
Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections.
Ann Intern Med 2006; 144(5):309–317. - Tenover FC, McDougal LK, Goering RV, et al. Characterization of a strain of community-associated
methicillin-resistant Staphylococcus aureus widely disseminated in the United States. J Clin
Microbiol 2006; 44(1):108–118. - Stryjewski ME, Chambers HF. Skin and soft-tissue infections caused by community-acquired
methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2008; 46(suppl 5):S368–S377. - Miller LG, Perdeau-Remington F, Reig G, et al. Necrotizing fasciitis caused by community associated
methicillin resistant Staphylococcus aureus in Los Angeles. N Engl J Med 2005; 352:1445–1453. - Klevens RM, Morrison MA, Nadle J, et al. Invasive methicillin-resistant Staphylococcus aureus
infections in the United States. JAMA 2007; 298(15):1763–1771. - Saravolatz LD, Pawlak J, Johnson LB. Comparative activity of telavancin against isolates of
community-associated methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 2007;
60(2):406–409. - Stryjewski ME, Graham DR, Wilson S, et al. Telavancin versus vancomycin for the treatment of
complicated skin and skin-structure infections caused by gram-positive organisms. Clin Infect Dis
2008; 46:1683–1693. - Noel GJ, Strauss RS, Amsler K, et al. Results of a double-blind, randomized trial of ceftobiprole
treatment of complicated skin and skin structure infections caused by gram positive bacteria.
Antimicrob Agents Chemother 2008; 52:37–44.
Severe Skin and Soft Tissue Infections in Critical Care 321